Literature DB >> 18072098

Use of neostigmine for the management of drug induced ileus in severe poisonings.

Betty Chan1, Ian Whyte, Andrew Dawson, Michael Downes.   

Abstract

INTRODUCTION: Effective whole bowel irrigation may be difficult in the presence of drug-induced ileus. Neostigmine, which inhibits the enzymatic degradation of acetylcholine, has been suggested to improve drug-induced ileus. We present two poisoning cases in which neostigmine was used to facilitate gut decontamination complicated by ileus. CASE REPORTS: A 47-year-old woman, after overdose with sodium valproate, venlafaxine, and ibuprofen, developed ileus that prevented whole bowel irrigation. Neostigmine, 2.5 mg intravenously followed by 1.25 mg three hours later, led to improved bowel transit and successful whole bowel irrigation. A 25-year-old man developed ileus after overdose with venlafaxine, dothiepin, and ethanol. Neostigmine administration led to improved intestinal motility and successful whole bowel irrigation. DISCUSSION: We demonstrate facilitated gut decontamination temporally associated with administration of neostigmine in two patients judged to have drug-induced ileus following overdose. No significant adverse events related to neostigmine were observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18072098

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  3 in total

1.  Comparing the Effect of Neostigmine and Metoclopramide on Gastric Residual Volume of Mechanically Ventilated Patients in Intensive Care Unit: A Double-Blind Randomized Clinical Trial.

Authors:  Alireza Rahat-Dahmardeh; Sara Saneie-Moghadam; Masoum Khosh-Fetrat
Journal:  Biomed Res Int       Date:  2021-08-16       Impact factor: 3.411

2.  Electrocardiogram changes and arrhythmias in venlafaxine overdose.

Authors:  Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2009-02-02       Impact factor: 4.335

3.  Evaluation of intravenous neostigmine infusion on tolerance of enteral nutrition in Intensive Care Unit patients.

Authors:  Omid Aghadavoudi; Saeed Abbasi; Parviz Kashefi; Mohammad Golparvar; Mohammadreza Habibzade; Shadi Kazemi
Journal:  J Res Med Sci       Date:  2013-09       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.